(Q43195362)

15 November 2017

title

Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals (English)

1 reference

15 November 2017

main subject

gram-positive bacteria

0 references

3

Jones RN

1 reference

15 November 2017

Sader HS

1

1 reference

15 November 2017

Moet GJ

series ordinal

2

1 reference

15 November 2017

publication date

1 December 2009

1 reference

15 November 2017

published in

Journal of Chemotherapy

1 reference

15 November 2017

volume

21

1 reference

15 November 2017

issue

6

1 reference

15 November 2017

page(s)

611-620

1 reference

Update on the in vitro activity of daptomycin tested against 17,193 Gram-positive bacteria isolated from European medical centers (2005-2007).

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Linezolid: the first oxazolidinone antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

United States resistance surveillance results for linezolid (LEADER Program for 2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Comparative in vitro activity of tigecycline against bacteria recovered from clinical specimens in Latin America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.6.611

10.1179/JOC.2009.21.6.611

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference